Quantcast

Latest lung cancer Stories

2014-04-07 12:33:09

Next-generation CyberKnife 10.0 Increases Accuracy, Reduces Treatment Time WESTERVILLE, Ohio, April 7, 2014 /PRNewswire/ -- Columbus CyberKnife, a service of Mount Carmel St. Ann's Hospital, recently completed a major upgrade of its cancer treatment technology to the next-generation CyberKnife(®) 10.0 system. http://photos.prnewswire.com/prnvar/20140407/DA98217 CyberKnife is a robotic technology that performs stereotactic body radiation therapy (SBRT), a nonsurgical method of...

2014-04-07 04:21:10

ROCKLAND, Massachusetts, April 7, 2014 /PRNewswire/ -- - First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries - START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who have demonstrated stable disease or objective response after concurrent chemoradiotherapy EMD Serono,...

2014-04-03 11:16:23

A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers. The findings, which were published this week online ahead of print by the journal Cancer, focus on a protein...

2014-04-01 23:30:30

MRHFM comments on new study showing associations between all levels of asbestos exposure and mesothelioma, lung cancer and laryngeal cancer. St. Louis, MO (PRWEB) April 01, 2014 When asbestos fibers are breathed in, they may get trapped in the lungs where they may remain for a long period of time. A recent study published in the Journal of Occupational and Environmental Medicine (JOEM) in January 2014, reported that even small amounts of asbestos can remain in the body and cause a number...

2014-03-31 23:25:26

New research report “NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool” worked out by GBI Research is now available at MarketPublishers.com. According to the study, the APAC NSCLC market is predicted to post a 6.3% CAGR to amount to USD 2.9 billion by 2019. London, UK (PRWEB) March 31, 2014 As for 2012, the non-small cell lung cancer (NSCLC) market in the APAC region was evaluated...

2014-03-31 09:54:57

UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help. Dr. Jerry Shay, Vice Chairman and Professor of Cell Biology at UT Southwestern, led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model. When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer,...

2014-03-28 23:04:53

Markets Research Reports.biz added deep and professional market research reports on "NSCLC Therapeutics In Asia-Pacific Markets To 2019 - Personalized Therapies Focus On Untapped Segment Of Squamous Cell Carcinoma To Expand Treatment Pool" Market Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis-details/nsclc-therapeutics-in-asia-pacific-markets-to-2019-personalized-therapies-focus-on-untapped-segment-of-squamous-cell-carcinoma-to-expand-treatment-pool....

2014-03-28 12:21:55

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cvsjq3/investigation ) has announced the addition of the "Investigation Report on China Pemetrexed Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug. This product is with huge growth potential in the market. Approved by FDA...

2014-03-27 12:31:28

Preventive services like HPV vaccination and colorectal cancer screening are important tools in reducing cancer rates ATLANTA, March 27, 2014 /PRNewswire-USNewswire/ -- Rates of invasive cancer cases among U.S. men and women dropped slightly from 459 per 100,000 persons in 2009 to 446 per 100,000 persons in 2010, according to a study by the Centers for Disease Control and Prevention. The highest rates were for prostate, female breast, lung and bronchus, and colon and rectum cancers, which...

2014-03-27 12:30:55

A St. Jude Children's Research Hospital-led study identified two adult cancer drugs with potential to improve treatment of a high-risk childhood brain tumor; the drugs are now part of a pediatric clinical trial MEMPHIS, Tenn., March 27, 2014 /PRNewswire-USNewswire/ -- The quest to improve survival of children with a high-risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »
Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related